Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

So, when comparing Netflix Standard vs Premium, which is right for you? Below, we break down the pros and cons of the two pricier options. If you’re ready to sign up, you can do so by hitting ...

Here’s how it works. The best running belts make it easy to carry your essentials without the hassle. No more bulging pockets in your running shorts or leggings, or juggling your phone ...

Copyright 2025 Associated Press. All rights reserved.

Indian biosimilar exports, presently valued at $0.8 billion, are expected to grow fivefold to $4.2 billion by 2030 and reach $30-35 billion by 2047 ...